Free Trial

Augmedix (AUGX) Stock Price, News & Analysis

+0.02 (+1.79%)
(As of 05/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
713,708 shs
Average Volume
572,272 shs
Market Capitalization
$55.82 million
P/E Ratio
Dividend Yield
Price Target

Augmedix MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
470.2% Upside
$6.50 Price Target
Short Interest
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth
From ($0.48) to ($0.36) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.56 out of 5 stars

AUGX stock logo

About Augmedix Stock (OTCMKTS:AUGX)

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

AUGX Stock Price History

AUGX Stock News Headlines

Lake Street Keeps Their Buy Rating on Augmedix (AUGX)
Benchmark Co. Keeps Their Buy Rating on Augmedix (AUGX)
AUGX Mar 2024 7.500 call
AUGX Apr 2024 5.000 call
Augmedix Inc
See More Headlines
Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Health Information Services
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
0 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$48.70 million
Book Value
$0.10 per share


Free Float
Market Cap
$55.82 million
Not Optionable
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Emmanuel Krakaris (Age 65)
    President, CEO, Secretary & Director
    Comp: $734.33k
  • Mr. Ian Shakil (Age 39)
    Founder, Chief Strategy Officer & Director
  • Ms. Sandra Breber (Age 66)
    Chief Operating Officer
    Comp: $446.05k
  • Mr. Saurav Chatterjee Ph.D. (Age 52)
    Chief Technology Officer
    Comp: $438.05k
  • Mr. Paul Louis Ginocchio (Age 54)
    Chief Financial Officer
  • Todd Holvick
    Head of Legal & Compliance
  • Lia Wallick
    Head of People
  • Dr. Davin Lundquist M.D.
    Chief Medical Officer
  • Mr. Jonathan Hawkins (Age 54)
    Chief Revenue Officer
    Comp: $417.71k
  • Mr. Tomer Levy
    Senior Vice President of Engineering

AUGX Stock Analysis - Frequently Asked Questions

What is Augmedix's stock price target for 2024?

0 brokerages have issued twelve-month price objectives for Augmedix's shares. Their AUGX share price targets range from $6.50 to $6.50. On average, they anticipate the company's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 470.2% from the stock's current price.
View analysts price targets for AUGX
or view top-rated stocks among Wall Street analysts.

How have AUGX shares performed in 2024?

Augmedix's stock was trading at $5.85 at the start of the year. Since then, AUGX stock has decreased by 80.5% and is now trading at $1.14.
View the best growth stocks for 2024 here

How were Augmedix's earnings last quarter?

Augmedix, Inc. (OTCMKTS:AUGX) announced its earnings results on Monday, May, 13th. The company reported ($0.12) EPS for the quarter, meeting the consensus estimate of ($0.12). The business earned $13.47 million during the quarter, compared to the consensus estimate of $13.25 million. Augmedix had a negative net margin of 57.70% and a negative trailing twelve-month return on equity of 980.09%.

How do I buy shares of Augmedix?

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AUGX) was last updated on 5/26/2024 by Staff

From Our Partners